Hemoglobin, albumin, lymphocytes and platelets (HALP) score as a predictor of survival in patients with glioblastoma (GBM).

Ozden Demır Guzin Demirag Furkan Cakmak Demet Işık Bayraktar Leman Tomak

Published in: BMC neurology (2024)

The HALP score measured at the beginning of treatment seems to have predictive importance in the prognosis of GBM patients. A HALP score of > 37.39 was associated with prolonged survival in high-grade brain tumors.

Keyphrases

high grade
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
free survival
peripheral blood
patient reported
replacement therapy